Objective :
1. Capacity expansion and upgradation of manufacturing facilities; 2. Establishment of a new R&D Centre; 3. Repayment / prepayment of certain outstanding borrowings; 4. Working capital requirements; 5. Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia); and 6. General corporate purposes